Day: November 19, 2024
Acquisition of Profitable, Cash Flow-Generating Business Broadens Service Offerings Across Energy Value Chain
DUBLIN, Ireland, Nov. 19, 2024 (GLOBE NEWSWIRE) — Fusion Fuel Green PLC (NASDAQ: HTOO) (“Fusion Fuel” or the “Company”), a leading green hydrogen technology and engineering company, today announced it has signed a binding agreement to acquire an approximately 70% ownership interest in Quality Industrial Corp., a Nevada corporation (“QIND”) (OTC PINK: QIND) from its controlling shareholders (“the QIND sellers”). QIND operates in the gas supply and services sector, with expertise across the industrial and utility value chain. This acquisition, which the Company expects to close shortly, marks a pivotal step in Fusion Fuel’s strategy to build a full-service energy engineering business, combining capabilities in both...
EuroDry Ltd. Reports Results for the Nine-Month Period and Quarter Ended September 30, 2024
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
ATHENS, Greece, Nov. 19, 2024 (GLOBE NEWSWIRE) — EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today its results for the three and nine-month periods ended September 30, 2024.
Third Quarter 2024 Highlights:Total net revenues for the quarter of $14.7 million.Net loss attributable to controlling shareholders, of $4.2 million or $1.53 loss per share basic and diluted, respectively.Adjusted net loss1 attributable to controlling shareholders for the quarter of $3.9 million or $1.42 loss per share basic and diluted, respectively.Adjusted EBITDA1 for the quarter was $0.5 million.An average of 13.0 vessels were owned and operated during the third quarter of 2024 earning an average time charter equivalent...
TowerBrook and CD&R Complete Acquisition of R1 RCM
Written by Customer Service on . Posted in Mergers And Acquisitions.
R1 RCM Becomes Privately Held Company; Joe Flanagan Reappointed as CEO
MURRAY, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) — R1 RCM Inc. (“R1”), a leader in automating revenue management for healthcare providers, today announced that investment funds affiliated with TowerBrook Capital Partners (“TowerBrook”) and Clayton, Dubilier & Rice (“CD&R”) have completed their previously announced acquisition of R1.
On August 1, 2024, TowerBrook, CD&R and R1 announced that they had entered into a definitive merger agreement under which all outstanding shares of R1 common stock that TowerBrook did not own would be acquired for $14.30 per share in cash, valuing R1 at approximately $8.9 billion.
With the completion of the transaction, R1’s common stock has ceased trading and will no longer be listed on Nasdaq. R1 also intends to make...
Blue Mantis Acquires Colligio; Launches Collaboration/Unified Communications Practice
Written by Customer Service on . Posted in Mergers And Acquisitions.
Acquisition Significantly Bolsters Blue Mantis’s Expertise and Capabilities in Delivering Best-in-Class UC Solutions to its Client Base
PORTSMOUTH, N.H., Nov. 19, 2024 (GLOBE NEWSWIRE) — Blue Mantis, a leading provider of digital strategy and services specializing in managed services, cybersecurity, and cloud solutions, today announced that it has acquired Colligio, a provider of unified communications, networking and security solutions, specializing in Cisco-based technologies, headquartered in Walpole, MA with customers and employees located throughout the Northeast.
With the acquisition, Blue Mantis is launching a new Collaboration/Unified Communications Practice, allowing it to take a more focused approach to delivering best-in-class collaboration and communication solutions, backed by world-class managed services. Colligio...
Star Equity Holdings, Inc. Announces 2024 Third Quarter Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Recent large commercial contract wins validate optimism for Building Solutions upturn
Enservco investment diversifies portfolio; marks entry into Energy Services and Transportation & Logistics
OLD GREENWICH, Conn., Nov. 19, 2024 (GLOBE NEWSWIRE) — Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star” or the “Company”), a diversified holding company, reported today its financial results for the third quarter (Q3) ended September 30, 2024. All 2024 and 2023 amounts in this release are unaudited.
Following the sale of our Digirad Health business on May 4, 2023, all financial results for the 2023 reporting period, unless stated otherwise, relate to continuing operations, which currently include two divisions: Building Solutions (formerly known as Construction) and Investments.
Q3 2024 Financial Highlights vs. Q3 2023 (unaudited)Revenues...
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
Written by Customer Service on . Posted in Public Companies.
BEDMINSTER, N.J., Nov. 19, 2024 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at three upcoming investor conferences:
Evercore 7th Annual HealthCONx ConferenceTuesday, December 3, 2024 at 10:50 a.m. ET in Miami, FL
Citi 2024 Global Healthcare ConferenceWednesday, December 4, 2024 at 3:15 p.m. ET in Miami, FL
Piper Sandler 36th Annual Healthcare ConferenceThursday, December 5, 2024 at 11:30 a.m. ET in New York, NY
A live and achieved webcast of the presentations can be accessed under “Events & Presentations” in the Investors section of the Company’s...
Digitalist Group Plc Oy – Managers’ Transactions
Written by Customer Service on . Posted in Public Companies.
Digitalist Group Plc Oy – Managers’ Transactions Person subject to the notification requirement
Name: Wilhelm Rosenlew
Position: Member of the Board/Deputy member
Issuer: Digitalist Group Plc Oy
LEI: 743700AL68PUX6JMS644 Notification type: INITIAL NOTIFICATION
Reference number: 84921/5/4 Transaction date: 2024-11-12
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009008007 6 / 7Nature of transaction: DISPOSAL Transaction details
(1): Volume: 440000 Unit price: 0.0182 EUR
(2): Volume: 40000 Unit price: 0.0186 EUR
(3): Volume: 40000 Unit price: 0.0182 EUR Aggregated transactions
(3): Volume: 520000 Volume weighted average price: 0.01823 EURAdditional information:
Digitalist Group Plc
CEO Magnus Leijonborg, tel. +46 76 315 8422, magnus.leijonborg@digitalistgroup.com
Chairman of the Board...
Hepsiburada to Announce Third Quarter 2024 Results on December 10, 2024
Written by Customer Service on . Posted in Public Companies.
ISTANBUL, Nov. 19, 2024 (GLOBE NEWSWIRE) — D-MARKET Electronic Services & Trading (d/b/a “Hepsiburada”) (NASDAQ: HEPS), a leading Turkish e-commerce platform, will report its unaudited financial results for the third quarter ending September 30, 2024 before the U.S. market opens on Tuesday, December 10, 2024.
Conference Call and Webcast DetailsHepsiburada’s management will host an analyst and investor conference call and live webcast to discuss its financial results at 16.00 İstanbul / 13.00 London / 8.00 a.m. New York time on Tuesday, December 10, 2024.
Live webcast can be accessed via https://87399.themediaframe.eu/links/hepsiburada241210.html.
A replay will be available on the Hepsiburada Investor Relations website https://investors.hepsiburada.com following the call.
Hepsiburada’s results presentation will be available...
EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis
Written by Customer Service on . Posted in Public Companies.
Treatment with robotic HIFU showed reduction in moderate and severe post-operative complications and reduced hospital stay compared to surgeryLYON, France, November 19, 2024 – EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced a moderated scientific presentation of clinical data comparing Focal One HIFU versus surgery for the treatment of deep infiltrating endometriosis at the 2024 AAGL Global Congress, which took place from November 16-19, 2024, in New Orleans, LA. The presentation was entitled, “Evaluation of rectal endometriosis treatment with high-intensity focused ultrasound versus surgery: a retrospective multicenter study”, and was delivered by Professor Gil Dubernard, Head of Gynecology Department at Croix-Rousse University Hospital, Lyon, France, and...
Novartis ranks first in 2024 Access to Medicine Index
Written by Customer Service on . Posted in Public Companies.
The Index spotlights Novartis leadership in research and development, and governance of access, with Novartis ranking first in these sub-topicsNovartis malaria access plans, widespread registration of products in LMICs, and inclusive business model to improve access to products in multiple countries were all highlighted as Best Practice across the industryNovartis has risen three places to secure the top spot on the 2024 Access to Medicine IndexBasel, November 19, 2024 – Novartis has ranked first in the 2024 Access to Medicine Index (ATMI) report published today, highlighting the company’s leadership in improving access to medicines around the world.
The Index, published every two years, is an independent report that assesses 20 of the world’s largest research-based pharmaceutical companies on their efforts to improve access to...